Eli Lilly Stock: A Deep Dive into Q3 Earnings

Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Market watchers are expecting strong growth driven by the robust sales of Lilly's blockbuster drugs, particularly the diabetes franchise. Howe

read more